N-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]pyrrolidin-2-one;N-[[1-[1-[4-(4-fluorophenyl)butyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]imidazolidin-2-one;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-N-methylacetamide;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-2-methylpropanamide;oxalic acid

C158H185F8N19O18 — CID 159053175

IUPACN-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]pyrrolidin-2-one;N-[[1-[1-[4-(4-fluorophenyl)butyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]imidazolidin-2-one;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-N-methylacetamide;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-2-methylpropanamide;oxalic acid
SMILESCC(=O)N(C)Cc1ccc2ccn(C3CCN(CCc4ccc(F)cc4)CC3)c2c1.CC(=O)NCc1ccc2ccn(C3CCN(CCCCc4ccc(F)cc4)CC3)c2c1.CC(=O)NCc1ccc2ccn(C3CCN(CCc4ccc(F)cc4F)CC3)c2c1.CC(C)C(=O)NCc1ccc2ccn(C3CCN(CCc4ccc(F)cc4)CC3)c2c1.O=C(O)C(=O)O.O=C(O)C(=O)O.O=C(O)C(=O)O.O=C1CCCN1Cc1ccc2ccn(C3CCN(CCc4ccc(F)cc4F)CC3)c2c1.O=C1NCCN1Cc1ccc2ccn(C3CCN(CCc4ccc(F)cc4)CC3)c2c1
InChIInChI=1S/C26H29F2N3O.2C26H32FN3O.C25H29FN4O.C25H30FN3O.C24H27F2N3O.3C2H2O4/c27-22-6-5-20(24(28)17-22)7-12-29-13-9-23(10-14-29)31-15-8-21-4-3-19(16-25(21)31)18-30-11-1-2-26(30)32;1-19(2)26(31)28-18-21-3-6-22-10-16-30(25(22)17-21)24-11-14-29(15-12-24)13-9-20-4-7-23(27)8-5-20;1-20(31)28-19-22-5-8-23-11-17-30(26(23)18-22)25-12-15-29(16-13-25)14-3-2-4-21-6-9-24(27)10-7-21;26-22-5-2-19(3-6-22)7-12-28-13-9-23(10-14-28)30-15-8-21-4-1-20(17-24(21)30)18-29-16-11-27-25(29)31;1-19(30)27(2)18-21-3-6-22-10-16-29(25(22)17-21)24-11-14-28(15-12-24)13-9-20-4-7-23(26)8-5-20;1-17(30)27-16-18-2-3-20-7-13-29(24(20)14-18)22-8-11-28(12-9-22)10-6-19-4-5-21(25)15-23(19)26;3*3-1(4)2(5)6/h3-6,8,15-17,23H,1-2,7,9-14,18H2;3-8,10,16-17,19,24H,9,11-15,18H2,1-2H3,(H,28,31);5-11,17-18,25H,2-4,12-16,19H2,1H3,(H,28,31);1-6,8,15,17,23H,7,9-14,16,18H2,(H,27,31);3-8,10,16-17,24H,9,11-15,18H2,1-2H3;2-5,7,13-15,22H,6,8-12,16H2,1H3,(H,27,30);3*(H,3,4)(H,5,6)
InChIKeyMWHUJVBNDRNFJG-UHFFFAOYSA-N
MW2790.32 g/mol
LogP25.66
Rot. Bonds39

About N-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]pyrrolidin-2-one;N-[[1-[1-[4-(4-fluorophenyl)butyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]imidazolidin-2-one;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-N-methylacetamide;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-2-methylpropanamide;oxalic acid

N-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]pyrrolidin-2-one;N-[[1-[1-[4-(4-fluorophenyl)butyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]imidazolidin-2-one;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-N-methylacetamide;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-2-methylpropanamide;oxalic acid (PubChem CID 159053175) has the molecular formula C158H185F8N19O18 and a molecular weight of 2790.32 g/mol. Its IUPAC name is N-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]pyrrolidin-2-one;N-[[1-[1-[4-(4-fluorophenyl)butyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]imidazolidin-2-one;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-N-methylacetamide;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-2-methylpropanamide;oxalic acid.

Molecular Properties

Compound NameN-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]pyrrolidin-2-one;N-[[1-[1-[4-(4-fluorophenyl)butyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]imidazolidin-2-one;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-N-methylacetamide;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-2-methylpropanamide;oxalic acid
PubChem CID159053175
Molecular FormulaC158H185F8N19O18
Molecular Weight2790.32 g/mol
Exact Mass2788.40
IUPAC NameN-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]pyrrolidin-2-one;N-[[1-[1-[4-(4-fluorophenyl)butyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]imidazolidin-2-one;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-N-methylacetamide;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-2-methylpropanamide;oxalic acid
SMILESCC(=O)N(C)Cc1ccc2ccn(C3CCN(CCc4ccc(F)cc4)CC3)c2c1.CC(=O)NCc1ccc2ccn(C3CCN(CCCCc4ccc(F)cc4)CC3)c2c1.CC(=O)NCc1ccc2ccn(C3CCN(CCc4ccc(F)cc4F)CC3)c2c1.CC(C)C(=O)NCc1ccc2ccn(C3CCN(CCc4ccc(F)cc4)CC3)c2c1.O=C(O)C(=O)O.O=C(O)C(=O)O.O=C(O)C(=O)O.O=C1CCCN1Cc1ccc2ccn(C3CCN(CCc4ccc(F)cc4F)CC3)c2c1.O=C1NCCN1Cc1ccc2ccn(C3CCN(CCc4ccc(F)cc4)CC3)c2c1
InChIInChI=1S/C26H29F2N3O.2C26H32FN3O.C25H29FN4O.C25H30FN3O.C24H27F2N3O.3C2H2O4/c27-22-6-5-20(24(28)17-22)7-12-29-13-9-23(10-14-29)31-15-8-21-4-3-19(16-25(21)31)18-30-11-1-2-26(30)32;1-19(2)26(31)28-18-21-3-6-22-10-16-30(25(22)17-21)24-11-14-29(15-12-24)13-9-20-4-7-23(27)8-5-20;1-20(31)28-19-22-5-8-23-11-17-30(26(23)18-22)25-12-15-29(16-13-25)14-3-2-4-21-6-9-24(27)10-7-21;26-22-5-2-19(3-6-22)7-12-28-13-9-23(10-14-28)30-15-8-21-4-1-20(17-24(21)30)18-29-16-11-27-25(29)31;1-19(30)27(2)18-21-3-6-22-10-16-29(25(22)17-21)24-11-14-28(15-12-24)13-9-20-4-7-23(26)8-5-20;1-17(30)27-16-18-2-3-20-7-13-29(24(20)14-18)22-8-11-28(12-9-22)10-6-19-4-5-21(25)15-23(19)26;3*3-1(4)2(5)6/h3-6,8,15-17,23H,1-2,7,9-14,18H2;3-8,10,16-17,19,24H,9,11-15,18H2,1-2H3,(H,28,31);5-11,17-18,25H,2-4,12-16,19H2,1H3,(H,28,31);1-6,8,15,17,23H,7,9-14,16,18H2,(H,27,31);3-8,10,16-17,24H,9,11-15,18H2,1-2H3;2-5,7,13-15,22H,6,8-12,16H2,1H3,(H,27,30);3*(H,3,4)(H,5,6)
InChIKeyMWHUJVBNDRNFJG-UHFFFAOYSA-N
XLogP25.66
TPSA433.08 Ų
H-Bond Donors10
H-Bond Acceptors24
Rotatable Bonds39
Heavy Atoms203
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002790.32
LogP ≤ 525.66
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'diketo_group', 'substructure': 'N/A'}

Analyze N-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]pyrrolidin-2-one;N-[[1-[1-[4-(4-fluorophenyl)butyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]imidazolidin-2-one;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-N-methylacetamide;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-2-methylpropanamide;oxalic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]pyrrolidin-2-one;N-[[1-[1-[4-(4-fluorophenyl)butyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]imidazolidin-2-one;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-N-methylacetamide;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-2-methylpropanamide;oxalic acid?
The IUPAC name of N-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]pyrrolidin-2-one;N-[[1-[1-[4-(4-fluorophenyl)butyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]imidazolidin-2-one;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-N-methylacetamide;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-2-methylpropanamide;oxalic acid (CID 159053175) is N-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]pyrrolidin-2-one;N-[[1-[1-[4-(4-fluorophenyl)butyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]imidazolidin-2-one;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-N-methylacetamide;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-2-methylpropanamide;oxalic acid.
What is the SMILES notation for N-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]pyrrolidin-2-one;N-[[1-[1-[4-(4-fluorophenyl)butyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]imidazolidin-2-one;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-N-methylacetamide;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-2-methylpropanamide;oxalic acid?
The canonical SMILES for N-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]pyrrolidin-2-one;N-[[1-[1-[4-(4-fluorophenyl)butyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]imidazolidin-2-one;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-N-methylacetamide;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-2-methylpropanamide;oxalic acid is CC(=O)N(C)Cc1ccc2ccn(C3CCN(CCc4ccc(F)cc4)CC3)c2c1.CC(=O)NCc1ccc2ccn(C3CCN(CCCCc4ccc(F)cc4)CC3)c2c1.CC(=O)NCc1ccc2ccn(C3CCN(CCc4ccc(F)cc4F)CC3)c2c1.CC(C)C(=O)NCc1ccc2ccn(C3CCN(CCc4ccc(F)cc4)CC3)c2c1.O=C(O)C(=O)O.O=C(O)C(=O)O.O=C(O)C(=O)O.O=C1CCCN1Cc1ccc2ccn(C3CCN(CCc4ccc(F)cc4F)CC3)c2c1.O=C1NCCN1Cc1ccc2ccn(C3CCN(CCc4ccc(F)cc4)CC3)c2c1.
What is the InChIKey of N-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]pyrrolidin-2-one;N-[[1-[1-[4-(4-fluorophenyl)butyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]imidazolidin-2-one;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-N-methylacetamide;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-2-methylpropanamide;oxalic acid?
The InChIKey is MWHUJVBNDRNFJG-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H29F2N3O.2C26H32FN3O.C25H29FN4O.C25H30FN3O.C24H27F2N3O.3C2H2O4/c27-22-6-5-20(24(28)17-22)7-12-29-13-9-23(10-14-29)31-15-8-21-4-3-19(16-25(21)31)18-30-11-1-2-26(30)32;1-19(2)26(31)28-18-21-3-6-22-10-16-30(25(22)17-21)24-11-14-29(15-12-24)13-9-20-4-7-23(27)8-5-20;1-20(31)28-19-22-5-8-23-11-17-30(26(23)18-22)25-12-15-29(16-13-25)14-3-2-4-21-6-9-24(27)10-7-21;26-22-5-2-19(3-6-22)7-12-28-13-9-23(10-14-28)30-15-8-21-4-1-20(17-24(21)30)18-29-16-11-27-25(29)31;1-19(30)27(2)18-21-3-6-22-10-16-29(25(22)17-21)24-11-14-28(15-12-24)13-9-20-4-7-23(26)8-5-20;1-17(30)27-16-18-2-3-20-7-13-29(24(20)14-18)22-8-11-28(12-9-22)10-6-19-4-5-21(25)15-23(19)26;3*3-1(4)2(5)6/h3-6,8,15-17,23H,1-2,7,9-14,18H2;3-8,10,16-17,19,24H,9,11-15,18H2,1-2H3,(H,28,31);5-11,17-18,25H,2-4,12-16,19H2,1H3,(H,28,31);1-6,8,15,17,23H,7,9-14,16,18H2,(H,27,31);3-8,10,16-17,24H,9,11-15,18H2,1-2H3;2-5,7,13-15,22H,6,8-12,16H2,1H3,(H,27,30);3*(H,3,4)(H,5,6).
What are the key properties of N-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]pyrrolidin-2-one;N-[[1-[1-[4-(4-fluorophenyl)butyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]imidazolidin-2-one;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-N-methylacetamide;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-2-methylpropanamide;oxalic acid?
N-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]pyrrolidin-2-one;N-[[1-[1-[4-(4-fluorophenyl)butyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]imidazolidin-2-one;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-N-methylacetamide;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-2-methylpropanamide;oxalic acid has a molecular weight of 2790.32 g/mol, XLogP of 25.66, 39 rotatable bonds, 10 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(2,4-difluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]pyrrolidin-2-one;N-[[1-[1-[4-(4-fluorophenyl)butyl]piperidin-4-yl]indol-6-yl]methyl]acetamide;1-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]imidazolidin-2-one;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-N-methylacetamide;N-[[1-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]indol-6-yl]methyl]-2-methylpropanamide;oxalic acid is sourced from PubChem (CID 159053175), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).